Can sleep apnea lower testosterone?

Yes, sleep apnea can significantly lower testosterone levels by disrupting sleep quality and oxygen supply, with studies showing 10-15% reductions in men with untreated OSA. Treatment with CPAP therapy can help restore testosterone levels within 3-12 months.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

The Direct Link Between Sleep Apnea and Low Testosterone

Sleep apnea and testosterone deficiency share a complex bidirectional relationship that affects millions of men worldwide. Research consistently shows that men with obstructive sleep apnea (OSA) have significantly lower testosterone levels compared to those without the condition. A landmark study published in the Journal of Clinical Endocrinology & Metabolism found that men with severe sleep apnea had testosterone levels that were 10-15% lower than healthy controls, with some experiencing reductions of up to 30%.

The connection makes biological sense when you consider that testosterone production follows a circadian rhythm, with the highest levels occurring during REM sleep. Sleep apnea repeatedly interrupts these crucial sleep stages, preventing the body from completing its natural hormone production cycles. Each apnea episode triggers a stress response that further suppresses testosterone synthesis, creating a vicious cycle of poor sleep and hormonal imbalance.

Understanding your current testosterone levels is crucial for identifying whether sleep apnea might be affecting your hormonal health. Regular monitoring can help track improvements as you address sleep issues.

Symptom Comparison: Sleep Apnea vs Low Testosterone vs Both Conditions

Symptoms intensify significantly when both conditions are present, making diagnosis and treatment more urgent.
Symptom CategorySleep Apnea AloneLow Testosterone AloneBoth Conditions
Fatigue LevelFatigue LevelModerate daytime sleepinessLow energy throughout daySevere fatigue, especially mornings
Sexual FunctionSexual FunctionMild libido changesReduced libido, ED (30%)Severe ED (60-70%), very low libido
Cognitive ImpactCognitive ImpactConcentration issuesMild brain fogSevere memory problems, poor focus
Mood ChangesMood ChangesIrritabilityDepression (20%)Depression (40%), anxiety, mood swings
Physical SymptomsPhysical SymptomsSnoring, gaspingMuscle loss, weight gainAll symptoms intensified

Symptoms intensify significantly when both conditions are present, making diagnosis and treatment more urgent.

How Sleep Apnea Disrupts Testosterone Production

Oxygen Deprivation and Hormonal Synthesis

During sleep apnea episodes, your body experiences repeated drops in blood oxygen levels, known as intermittent hypoxia. The Leydig cells in your testes, which are responsible for producing testosterone, are particularly sensitive to oxygen levels. Studies have shown that even mild hypoxia can reduce testosterone production by up to 25% within just a few hours. This oxygen deprivation directly impairs the enzymatic processes required for converting cholesterol into testosterone.

The hypothalamic-pituitary-gonadal (HPG) axis, which regulates testosterone production, becomes dysregulated under conditions of chronic intermittent hypoxia. The pituitary gland reduces its production of luteinizing hormone (LH), the primary signal that tells the testes to produce testosterone. Research indicates that men with severe OSA show 20-30% lower LH levels during sleep compared to healthy individuals.

Sleep Fragmentation and REM Sleep Loss

Sleep apnea causes frequent micro-awakenings throughout the night, preventing you from reaching and maintaining deep sleep stages. Since approximately 70% of daily testosterone release occurs during REM sleep, the fragmentation caused by sleep apnea severely limits hormone production. Men with moderate to severe OSA spend 15-20% less time in REM sleep compared to those without the condition.

The timing of testosterone production is also disrupted. Normal testosterone secretion follows a pulsatile pattern with 6-8 pulses during sleep. Sleep apnea reduces both the number and amplitude of these pulses, leading to a flattened daily testosterone rhythm that affects energy, mood, and sexual function throughout the day.

Stress Response and Cortisol Elevation

Each apnea event triggers a stress response, causing spikes in cortisol and adrenaline. Chronically elevated cortisol directly suppresses testosterone production through multiple mechanisms. It inhibits GnRH release from the hypothalamus, reduces LH sensitivity in the testes, and competes for the same enzymatic pathways needed for testosterone synthesis. Men with untreated sleep apnea show cortisol levels that are 20-50% higher than normal, particularly in the evening when cortisol should naturally be declining.

Recognizing the Combined Symptoms

When sleep apnea and low testosterone occur together, the symptom overlap can make diagnosis challenging. Both conditions share common manifestations including chronic fatigue, decreased libido, erectile dysfunction, mood changes, and difficulty concentrating. However, certain symptom patterns can help identify when both conditions are present. Understanding these patterns is essential for proper diagnosis and treatment.

Physical symptoms tend to be more pronounced when both conditions coexist. Men often report severe morning fatigue despite spending adequate time in bed, along with headaches, dry mouth, and sore throat from mouth breathing during apnea episodes. Sexual dysfunction becomes particularly problematic, with studies showing that 60-70% of men with both conditions experience moderate to severe erectile dysfunction compared to 30% with low testosterone alone.

Cognitive and emotional symptoms also intensify with the combination. Brain fog, memory problems, and difficulty with decision-making become more severe. Depression rates double when both conditions are present, affecting up to 40% of men with comorbid sleep apnea and testosterone deficiency. Irritability and mood swings often strain relationships, creating additional stress that further suppresses testosterone production.

Risk Factors and Who Should Be Concerned

Certain populations face higher risks of developing both sleep apnea and testosterone deficiency. Men over 40 are particularly vulnerable, as testosterone naturally declines with age while sleep apnea risk increases. Obesity significantly elevates risk for both conditions - excess weight contributes to airway obstruction and increases aromatase activity, which converts testosterone to estrogen. Men with a BMI over 30 have a 50% higher risk of having both conditions compared to those with normal weight.

Medical conditions also increase susceptibility. Type 2 diabetes doubles the risk of both sleep apnea and low testosterone. Metabolic syndrome, characterized by insulin resistance, high blood pressure, and abnormal cholesterol levels, is present in 60% of men with both conditions. Cardiovascular disease, particularly hypertension, correlates strongly with sleep apnea and can further suppress testosterone through reduced testicular blood flow.

Lifestyle factors play a crucial role. Shift workers face a 30% higher risk due to circadian rhythm disruption. Alcohol consumption, especially before bed, worsens sleep apnea and directly suppresses testosterone synthesis. Sedentary behavior contributes to weight gain and muscle loss, creating a cycle that worsens both conditions. Men taking certain medications, including opioids, corticosteroids, and some antidepressants, should be particularly vigilant as these drugs can suppress testosterone and worsen sleep quality.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Testing and Diagnosis Strategies

Sleep Studies and Hormone Testing

Proper diagnosis requires comprehensive evaluation of both sleep patterns and hormone levels. A polysomnography (sleep study) remains the gold standard for diagnosing sleep apnea, measuring the apnea-hypopnea index (AHI) to determine severity. An AHI of 5-15 indicates mild OSA, 15-30 moderate, and over 30 severe. Home sleep tests offer a convenient alternative for initial screening, though they may underestimate severity in some cases.

Testosterone testing should be performed in the morning when levels are naturally highest, ideally between 7-10 AM. Total testosterone below 300 ng/dL generally indicates deficiency, though symptoms can occur at higher levels. Free testosterone, which represents the bioavailable hormone, provides additional diagnostic value. Comprehensive hormone panels should include LH, FSH, prolactin, and SHBG to identify the underlying cause of testosterone deficiency.

Additional Biomarkers to Consider

Beyond basic hormone levels, several biomarkers can provide insight into the metabolic consequences of sleep apnea and low testosterone. Inflammatory markers like high-sensitivity C-reactive protein (hs-CRP) are often elevated in both conditions. Insulin resistance markers, including fasting glucose and hemoglobin A1c, help assess metabolic health. Lipid panels frequently show elevated triglycerides and reduced HDL cholesterol in men with both conditions.

Cortisol rhythm testing can reveal the stress response patterns associated with sleep apnea. A flattened cortisol curve, with elevated evening levels, indicates chronic stress and poor sleep quality. Vitamin D deficiency, present in 60-80% of men with sleep apnea, can further suppress testosterone production and should be assessed.

Treatment Approaches and Recovery Timeline

CPAP Therapy and Testosterone Recovery

Continuous positive airway pressure (CPAP) therapy remains the most effective treatment for moderate to severe sleep apnea. Studies show that consistent CPAP use can increase testosterone levels by 10-15% within three months, with continued improvements up to 12 months. The response varies based on compliance, with men using CPAP for more than 4 hours nightly showing significantly better hormonal recovery. Some men experience testosterone increases of 100-150 ng/dL with optimal CPAP adherence.

The timeline for testosterone recovery with CPAP follows a predictable pattern. Initial improvements in morning testosterone levels occur within 2-4 weeks as sleep quality improves. LH and FSH levels normalize within 6-8 weeks, indicating restoration of the HPG axis. Maximum testosterone recovery typically occurs at 3-12 months, though men with severe, long-standing sleep apnea may require longer for full recovery. Regular monitoring helps track progress and adjust treatment as needed.

Lifestyle Modifications for Dual Benefit

Weight loss provides substantial benefits for both conditions. A 10% reduction in body weight can decrease AHI by 26% and increase testosterone by 50-100 ng/dL in obese men. Combining dietary changes with resistance training optimizes results, as muscle mass supports testosterone production while improving metabolic health. Mediterranean-style diets rich in healthy fats and antioxidants support hormone production and reduce inflammation associated with sleep apnea.

Exercise timing matters for managing both conditions. Morning or afternoon workouts improve sleep quality without interfering with bedtime. High-intensity interval training (HIIT) 3-4 times weekly can increase testosterone by 15-20% while improving cardiovascular fitness. Strength training twice weekly maintains muscle mass and bone density, both affected by low testosterone. Avoid intense exercise within 3 hours of bedtime, as it can worsen sleep quality.

When to Consider Hormone Replacement

Testosterone replacement therapy (TRT) may be appropriate when CPAP and lifestyle changes fail to restore adequate hormone levels. However, TRT in men with untreated sleep apnea requires careful consideration, as testosterone can worsen OSA by increasing upper airway collapse and stimulating erythropoiesis, which thickens blood. Most experts recommend treating sleep apnea for at least 3-6 months before considering TRT.

If TRT is initiated, close monitoring is essential. Sleep studies should be repeated after starting treatment to ensure OSA hasn't worsened. Hematocrit levels require regular monitoring, as elevated red blood cell counts increase cardiovascular risk. Some men benefit from lower, more physiologic TRT doses combined with lifestyle interventions rather than aggressive hormone replacement.

Long-term Health Implications

Untreated sleep apnea and testosterone deficiency create a cascade of health problems that compound over time. Cardiovascular risk increases exponentially when both conditions coexist. Men with both conditions face a 2-3 fold higher risk of heart attack and stroke compared to those with neither condition. The combination accelerates atherosclerosis, with carotid intima-media thickness increasing 20% faster than in healthy individuals.

Metabolic consequences are equally concerning. The risk of developing type 2 diabetes increases by 60% when both conditions are present. Insulin resistance worsens progressively, with many men developing metabolic syndrome within 5 years if left untreated. Bone density decreases more rapidly, with osteoporosis risk doubling compared to men with normal testosterone and sleep patterns.

Cognitive decline accelerates with chronic sleep apnea and low testosterone. Memory problems and executive dysfunction become apparent within 2-3 years of onset. The risk of developing mild cognitive impairment increases by 40%, with some studies suggesting links to earlier onset of dementia. Depression and anxiety disorders affect up to 50% of men with both conditions, significantly impacting quality of life and relationships.

Prevention Strategies and Monitoring

Preventing the development of sleep apnea and maintaining healthy testosterone levels requires proactive lifestyle management. Maintaining a healthy weight through balanced nutrition and regular exercise reduces risk by up to 50%. Sleep hygiene practices, including consistent sleep schedules and avoiding alcohol before bed, support both respiratory function and hormone production. Side sleeping can reduce mild sleep apnea severity by 30-50% in positional cases.

Regular health screening helps identify problems early when they're most treatable. Annual testosterone checks starting at age 40, or earlier with symptoms, allow for early intervention. Sleep apnea screening should be considered for anyone with snoring, witnessed apneas, or daytime fatigue. Comprehensive metabolic panels help track the downstream effects of both conditions on overall health.

For those already diagnosed with one condition, vigilant monitoring for the other is crucial. Men with sleep apnea should have testosterone levels checked annually, while those with low testosterone should be screened for sleep disorders. This bidirectional screening approach ensures comprehensive care and optimal treatment outcomes.

If you're experiencing symptoms of low testosterone or sleep disturbances, getting a comprehensive hormone panel can provide valuable insights into your health status. Upload your existing blood test results to SiPhox Health's free analysis service for personalized insights and recommendations tailored to your unique profile.

Taking Action for Better Health

The relationship between sleep apnea and testosterone deficiency represents a critical but often overlooked aspect of men's health. Understanding this connection empowers you to take control of both conditions simultaneously. The good news is that treating sleep apnea often leads to natural testosterone recovery, while addressing low testosterone can improve sleep quality and reduce apnea severity in some cases.

Success requires a comprehensive approach addressing both conditions together rather than in isolation. This means working with healthcare providers who understand the intricate relationship between sleep and hormones. It means being patient with treatment, as hormonal recovery takes time even with optimal therapy. Most importantly, it means making sustainable lifestyle changes that support both respiratory health and hormone production.

The path to recovery is well-established and achievable. With proper diagnosis, appropriate treatment, and consistent follow-up, most men experience significant improvements in both testosterone levels and sleep quality within 3-6 months. The key is starting treatment early before complications develop and maintaining long-term adherence to therapy. Your health, vitality, and quality of life depend on addressing these interconnected conditions comprehensively.

References

  1. Luboshitzky, R., Aviv, A., Hefetz, A., Herer, P., & Lavie, L. (2002). Decreased pituitary-gonadal secretion in men with obstructive sleep apnea. Journal of Clinical Endocrinology & Metabolism, 87(7), 3394-3398.[PubMed][DOI]
  2. Zhang, X. B., Lin, Q. C., Zeng, H. Q., Jiang, X. T., Chen, B., & Chen, X. (2016). Erectile dysfunction and sexual hormone levels in men with obstructive sleep apnea: efficacy of continuous positive airway pressure. Archives of Sexual Behavior, 45(1), 235-240.[PubMed][DOI]
  3. Celec, P., Mucska, I., Ostatnikova, D., & Hodosy, J. (2014). Testosterone and estradiol are not affected in male and female patients with obstructive sleep apnea treated with continuous positive airway pressure. Journal of Endocrinological Investigation, 37(1), 9-12.[PubMed][DOI]
  4. Bercea, R. M., Mihaescu, T., & Cojocaru, C. (2015). Fatigue and serum testosterone in obstructive sleep apnea patients. Clinical Respiratory Journal, 9(3), 342-349.[PubMed][DOI]
  5. Wittert, G. (2014). The relationship between sleep disorders and testosterone in men. Asian Journal of Andrology, 16(2), 262-265.[PubMed][DOI]
  6. Liu, P. Y., Yee, B., Wishart, S. M., Jimenez, M., Jung, D. G., Grunstein, R. R., & Handelsman, D. J. (2003). The short-term effects of high-dose testosterone on sleep, breathing, and function in older men. Journal of Clinical Endocrinology & Metabolism, 88(8), 3605-3613.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my testosterone at home?

You can test your testosterone at home with SiPhox Health's Hormone Focus Program. This CLIA-certified program includes comprehensive testosterone testing along with other key hormones, providing lab-quality results from the comfort of your home.

How quickly can testosterone levels recover after starting CPAP therapy?

Initial improvements in testosterone can occur within 2-4 weeks of consistent CPAP use. Most men see significant increases within 3 months, with maximum recovery typically occurring between 3-12 months depending on compliance and severity of the original deficiency.

What testosterone level indicates a deficiency?

Total testosterone below 300 ng/dL is generally considered deficient, though symptoms can occur at higher levels. The optimal range for most men is 450-600 ng/dL, with levels ideally tested in the morning when they're naturally highest.

Can losing weight improve both sleep apnea and testosterone?

Yes, weight loss significantly benefits both conditions. A 10% reduction in body weight can decrease sleep apnea severity by 26% and increase testosterone by 50-100 ng/dL in obese men, making it one of the most effective interventions.

Should I treat sleep apnea before starting testosterone replacement therapy?

Yes, most experts recommend treating sleep apnea for at least 3-6 months before considering TRT. Testosterone can potentially worsen untreated sleep apnea by increasing upper airway collapse and blood thickness.

What are the first signs that sleep apnea is affecting testosterone?

Early signs include severe morning fatigue despite adequate sleep time, decreased morning erections, reduced libido, difficulty concentrating, and mood changes. These symptoms often develop gradually and worsen over time.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details